In AML, the function of NK cells can be inhibited by various factors, including the presence of multiple immunosuppressive factors in the TME, such as TGF-β and IL-10 (Figure 2a), which inhibit the activity and proliferation of NK cells (139). The gene discussed is TGFB1; the disease is acute myeloid leukemia.